Company Press Releases

Angle PLC: Total Voting Rights

2017-10-26 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 26, 2017) -Angle PLC (OTCQX: ANPCY) (AIM: AGL) AIM:AGL OTCQX:ANPCY For immediate release 26 October 2017 ANGLE plc ("the Company") Total Voting Rights ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces t...Read More

Angle PLC: Researchers Develop Parsortix(TM)-Based Process to Efficiently Harvest Cancer Cells From Bone Marrow

2017-10-23 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 23, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 23 October 2017 ANGLE plc ("the Company") RESEARCHERS DEVELOP PARSORTIX?,,?-BASED PROCESS TO EFFICIENTLY HARVEST CANCER CELLS FROM BONE MARROW Reactivation o...Read More

ANGLE plc: Notice of AGM

2017-10-20 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 20, 2017) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 20 October 2017 ANGLE plc ("the Company") Annual Report and Accounts and Notice of AGM ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid...Read More

Seventh Peer Reviewed Publication on Angle's Parsortix(TM) System

2017-10-17 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 17, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 17 October 2017 ANGLE plc ("the Company") SEVENTH PEER REVIEWED PUBLICATION ON ANGLE'S PARSORTIX?,,? SYSTEM Parsortix?,,? system outperforms other appr...Read More

ANGLE plc Announces Proposed Further Subscription for ? 2.8 Million

2017-10-12 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 12, 2017) -ANGLE plc (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 12 October 2017 ANGLE plc ("the Company") PROPOSED FURTHER SUBSCRIPTION FOR ?2.8 MILLION ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid...Read More

Angle's Parsortix(TM) System Showcased in Multiple Presentations at Leading European Circulating Tumour Cell Conference

2017-10-09 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Oct 9, 2017) -Angle PLC (OTCQX: ANPCY) (AIM: AGL) AIM: AGL; OTCQX: ANPCY For immediate release 9 October 2017 ANGLE plc ("the Company") ANGLE'S PARSORTIX?,,? SYSTEM SHOWCASED IN MULTIPLE PRESENTATIONS AT LEADING EUROPEAN CIRCULATING TUMOU...Read More

ANGLE plc Announces Parsortix(TM) System Central to Potential New Analytical Protocol for Identifying Drugs That May Arrest Metastasis

2017-10-09 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 9, 2017) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY) AIM: AGL; OTCQX: ANPCY For immediate release 9 October 2017 ANGLE plc ("the Company") PARSORTIX?,,? SYSTEM CENTRAL TO POTENTIAL NEW ANALYTICAL PROTOCOL FOR IDENTIFYING DRUGS THAT MAY A...Read More

ANGLE plc Announces Circulating Tumour Cells, Harvested From Blood, Grown in the Laboratory for the First Time

2017-10-09 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 9, 2017) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY), AIM: AGL; OTCQX: ANPCY For immediate release 9 October 2017 ANGLE plc ("the Company") CIRCULATING TUMOUR CELLS, HARVESTED FROM BLOOD, GROWN IN THE LABORATORY FOR THE FIRST TIME Heinr...Read More

Angle PLC: Angle PLC Announces Proposed Placing of 29,437,152 New Ordinary Shares at 35 pence per share Proposed subscriptions of 5,352,026 New Ordinary Shares at 35 pence per share Conditional Acquisition of certain assets of Axela Inc.

2017-10-05 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 5, 2017) -Angle PLC (OTCQX: ANPCY) (AIM: AGL) (AIM: AGL; OTCQX: ANPCY) THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR IN...Read More

Angle PLC: Results of Fundraising

2017-10-05 / @marketwired

GUILDFORD, SURREY--(Marketwired - Oct 5, 2017) - Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM:AGL OTCQX:ANPCY) THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FRO...Read More

Angle PLC: Exclusive Worldwide Option Over Megakaryocyte Intellectual Property

2017-09-13 / @marketwired

GUILDFORD, SURREY--(Marketwired - Sep 13, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM:AGL OTCQX:ANPCY) For immediate release 13 September 2017 ANGLE plc ("the Company") EXCLUSIVE WORLDWIDE OPTION OVER MEGAKARYOCYTE INTELLECTUAL PROPERTY ANGLE signs option over patent applications...Read More

Angle PLC: Holding(s) in Company

2017-09-13 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Sep 13, 2017) -(AIM: AGL) (OTCQX: ANPCY) TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Ident...Read More

ANGLE Announces Co-Marketing Partnership With Qiagen

2017-09-11 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Sep 11, 2017) - Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL; OTCQX:ANPCY ANGLE plc ("the Company") ANGLE ANNOUNCES CO-MARKETING PARTNERSHIP WITH QIAGEN Combines ANGLE's CTC harvesting technology with QIAGEN's downstream analysis and b...Read More

Angle PLC: Change of Adviser

2017-09-05 / @marketwired

GUILDFORD, SURREY--(Marketwired - Sep 5, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY), (AIM: AGL OTCQX: ANPCY) 5 September 2017 ANGLE plc ("the Company") Change of Adviser ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, is pleased to announce the...Read More

Angle PLC Announces New Research With Parsortix Demonstrates Ability to Identify Key Proteins Involved in Breast Cancer Cell Growth and Survival

2017-09-04 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Sep 4, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM: AGL; OTCQX: ANPCY) For immediate release 4 September 2017 ANGLE plc ("the Company") NEW RESEARCH WITH PARSORTIX DEMONSTRATES ABILITY TO IDENTIFY KEY PROTEINS INVOLVED IN BREAST CANCER CELL...Read More

Angle PLC: Preliminary Results

2017-07-27 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 27, 2017) -ANGLE PLC (AIM: AGL) (OTCQX: ANPCY) For Immediate Release 27 July 2017 OTCQX: ANPCY ANGLE plc ("ANGLE" or "the Company") Preliminary Results for the year ended 30 April 2017 FIRST LARGE SCALE PATIENT STUDIES WITH PARSORTIX COM...Read More

ANGLE plc: Preclinical Study Presented At Tumor Boston Summit

2017-07-20 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 20, 2017) -ANGLE plc (AIM: AGL) (OTCQX: ANPCY) For immediate release 20 July 2017 ANGLE plc ("the Company") PRECLINICAL STUDY USING PARSORTIX PRESENTED AT TUMOR MODELS BOSTON SUMMIT Parsortix system demonstrates capabilities for use in cancer...Read More

Angle PLC: Notice of Results

2017-07-06 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 6, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) For Immediate Release 6 July 2017 AIM:AGL ANGLE plc ("ANGLE" or "the Company") Notification of Preliminary Results and Webcast ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy com...Read More

ANGLE Reports Successful Headline Data in US and European Ovarian Cancer Studies in 400 Patients

2017-07-04 / @marketwired

GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 4, 2017) -ANGLE plc (AIM: AGL) (OTCQX: ANPCY) (AIM: AGL; OTCQX: ANPCY) For immediate release 4 July 2017 ANGLE plc ("the Company") ANGLE REPORTS SUCCESSFUL HEADLINE DATA IN US AND EUROPEAN OVARIAN CANCER STUDIES IN 400 PATIENTS Parsortix bl...Read More

IIROC Trading Halt - AGLD

2017-06-08 / @newswire

VANCOUVER, June 8, 2017 /CNW/ - The following issues have been halted by IIROC: Company: Austral Gold Ltd. TSX-Venture Symbol: AGLD Reason: Pending Clarification of News Halt Time (ET): 09:22 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a...Read More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok